A data safety monitoring board recommended pausing the Phase 2b test of Pliant’s bexotegrast, an experimental treatment for idiopathic pulmonary fibrosis. The move follows a prespecified data review, the company said.
The post Pliant Therapeutics Presses Pause on Clinical Trial for Lung Disorder Drug appeared first on MedCity News.
